You have 9 free searches left this month | for more free features.

City

Beijing (1)

Chongqing (1)

Condition

Advanced Solid Tumor (1)

Stage III Non-small Cell Lung Cancer (1)

Overall Status

Not yet recruiting (2)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Shanghai Junshi Bioscience Co., Ltd. (1)

Shanghai Pulmonary Hospital, Shanghai, China (1)

Collaborator

Sponsor GmbH (1)

Intervention

js004 (2)

carboplatin (1)

nab-paclitaxel (1)

pemetrexed (1)

surgery (1)

toripalimab (1)

toripalimab injection (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

js004

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

Not yet recruiting

Stage III Non-small Cell Lung Cancer

Toripalimab
+5 more

(no location specified)

Jun 3, 2023

Advanced Solid Tumor Trial in Beijing, Chongqing (JS004, Toripalimab Injection)

Not yet recruiting

Advanced Solid Tumor

JS004
Toripalimab Injection

Beijing, Beijing, China
+1 more

Jun 16, 2022